Using Marijuana Every Day Could Help People Quit Opioids, New Study Indicates

A newly published study found that among drug users who experience chronic pain, daily cannabis use was linked to a higher likelihood of quitting the use of opioids—especially among men.

“Participants reporting daily cannabis use exhibited higher rates of cessation compared to less frequent users or non-users,” says the report, published last week in the journal Drug and Alcohol Review.

When results were split by sex, researchers observed that “daily cannabis use was significantly associated with increased rates of opioid cessation among males.” Those differences “suggest potential differences in cannabis use behavior and effects,” the paper says, and underscores the need for further research.

The report was authored by an eight-person research team from the British Columbia Centre on Substance Abuse as well as the University of British Columbia and Simon Fraser University.

Between June 2014 and May 2022, the team examined data from 1,242 people who used drugs (PWUD) while also living with chronic pain. Of those, 764 experienced “a cessation event.”

Daily cannabis use, it says, “was positively associated with opioid cessation.”

“Our findings add to the growing evidence supporting the potential benefits of cannabis use among PWUD, underlining the need for further research,” authors wrote.

Indeed, a growing body of research to date has examined the associations between cannabis reform and opioids, often finding reductions in opioid use in areas that legalize marijuana for medical or adult use.

A recent federally funded study in the U.S., for example, found an association between state-level marijuana legalization and reduced prescriptions for opioid pain medications among commercially insured adults—indicating a possible substitution effect where patients are choosing to use cannabis instead of prescription drugs to treat pain.

That research, which was supported by a grant from the National Institute on Drug Abuse, looked at national records of opioid prescription fills as well as prescribing of non-steroidal anti-inflammatory drugs (NSAIDs) and other pain medications. Analysis showed that prescription opioid fills dropped following legalization in U.S. while prescribing of non-opioid pain medications saw “marginally significant increases.”

Keep reading

California State Fair Will Again Feature On-Site Marijuana Sales And Consumption, With New Award Categories For Blunts, Hash And Chocolates

The California State Fair will once again feature a cannabis exhibit and competition at this year’s event, with expanded award categories meant to showcase the diversity of the state’s market.

This is the fourth year that California’s annual event has invited marijuana entrepreneurs and consumers to join the festivities—and, for the second year in a row, on-site sales and consumption will be permitted during the 17-day fair.

“Last year, we made history by integrating cannabis sales and consumption into the State Fair, and we are thrilled to return in 2025,” Lauren Carpenter, co-founder of Embarc, which is facilitating the sales component, said. “Through an immersive educational experience, we’re shining a light on the cannabis brands reflecting and shaping cannabis culture in California and beyond.”

As for the competition, there are 150 medals available this year. Submissions will open on March 1 and close on May 4. The winners will be announced at the start of the fair on July 11.

This year’s award categories have been expanded to include cannabis blunts, hash and chocolates.

“For more than 170 years the California State Fair has had a long-standing tradition of celebrating the best of the Golden State, especially those who epitomize the state’s agricultural excellence,” Tom Martinez, CEO of the California State Fair, said. “Since welcoming cannabis to the Fair, we’ve witnessed firsthand the pride and dedication of California’s cannabis cultivators, who are crafting some of the best products, not just in the state, but in the entire industry.”

Other categories up for awards include indoor, outdoor and mixed-light flower, beverages, cartridges, concentrates, edibles, pre-rolls and wellness.

Keep reading

Idaho Governor Signs Bill Setting Mandatory Minimum Fine For Marijuana Possession

Idaho’s governor has signed a bill creating a new mandatory minimum fine for possession of marijuana.

Under the legislation approved by Gov. Brad Little (R) on Monday, adults caught with less than three ounces of cannabis will face a mandatory minimum fine of $300.

Sponsor Rep. Bruce Skaug (R), the sponsor of the measure, told a House committee last month that “we do not want this to become a marijuana state.”

On the House floor, the representative asked colleagues: “Tell me what state—anybody who debates against this bill—what state is a better place because of the passage of marijuana legalization? I submit none.”

He later told a Senate committee that “a $300 fine is not too much if you can afford to buy this marijuana and concentrate.”

“Every dollar spent on pot by someone is not spent on food, clothing, school supplies, real medicine or housing,” he said.

The new law is set to take effect on July 1.

Keep reading

Using The Marijuana Components THC-V And CBD Every Day Helps People Lose Weight, Study Finds

Research on the use of marijuana components to aid weight loss found that use of a combined product containing the cannabinoids THCV and CBD “was associated with statistically significant weight loss” as well as a slimmer waistline, lower blood pressure and decreased cholesterol.

The study, published late last month in the journal Cannabis, analyzed outcomes among 44 people who were administered either oral strips containing a mixture of the two cannabinoids or a placebo. Participants took one strip daily for 90 says and were evaluated for weight loss and certain metabolic markers.

“Use of the THCV/CBD strip was associated with statistically significant weight loss, decreases in abdominal girth, systolic blood pressure, and total and LDL cholesterol,” says the report, authored by Dr. Gregory Smith, the founder and CEO of plant-based medicine company NeX Therapeutics, based in Florida.

Participants—31 of whom were female and 13 of whom were male, with a combined average age of about 52 years—were given either a placebo or one of two different mucoadhesive oral strips. A lower-dose version contained 8 milligrams of THCV and 10 mg CBD, while a higher-dose version had 16 mg THCV and 20 mg CBD. Subjects received a reminder to take a dose each day on an empty stomach and report any side effects, and they agreed to refrain from using cannabis or other cannabinoid-based products.

Participants were not asked to make any changes to their diet or exercise routines.

Of 24 people who received the lower-potency oral strips, 16 (66.7 percent) demonstrated weight loss over the course of the 90-day period—on average losing 2.6 kilograms (5.7 pounds). Among the 10 who received the higher-dose strips, seven (70 percent) lost weight—an average of 4.1 kg (9.0 lbs).

The 10 subjects who received the placebo, meanwhile, lost an average of just 0.1 kg (0.2 lbs).

Nearly all (95.8 percent) in the lower-dose group also saw reductions in abdominal girth, as did 70 percent of the higher-dose subjects.

“It is interesting to note that there was a barely statistically significant decrease in the control/placebo group,” Smith wrote, “however, it is also worth noting that abdominal girth is probably the least accurate of all the biometric measures taken for the purposes of this study.”

The THCV/CBD groups also showed reductions in systolic blood pressure as well as total and LDL cholesterol, the research found.

“In summary, 90 day use of once-daily THCV and CBD-infused mucoadhesive strips was associated with clinically significant weight loss, decreases in abdominal girth, systolic blood pressure, and total and LDL cholesterol,” the report concludes, adding that stronger dosage appeared to perform better: “The 16mg/20mg daily dose in Group B was superior for weight loss compared to the 8mg/10mg daily dose in Group A.”

Keep reading

Pennsylvania GOP Senator Calls Marijuana Prohibition A ‘Disaster,’ Signaling Support For Treating Cannabis Like Alcohol And Tobacco

Amid growing calls for marijuana legalization in Pennsylvania, a GOP state senator says prohibition has been a “disaster,” and a regulated sales model for cannabis—similar to how alcohol and tobacco are handled—could serve as an effective alternative.

Sen. Gene Yaw (R) said both alcohol and tobacco have been “used for thousands of years,” just like marijuana. Yet only cannabis continues to be strictly criminalized.

“I don’t think marijuana is any different than these other things,” Yaw told The Standard-Journal. “We’ve regulated it and taxed it.”

The senator noted that Pennsylvania lawmakers have introduced numerous cannabis reform bills over recent sessions. And while, years ago, “I never thought I would support medical marijuana,” he said he came around on the issue and voted for it because “it has its place for some people.”

Yaw didn’t explicitly endorse any specific recreational marijuana legalization proposals that have been filed for the 2025 session, but his description of prohibition as a “disaster” indicates a willingness to advance the reform at a key time in the Pennsylvania legislature.

Voters are ready to see that policy change, according to a poll released this week.

The survey found that nearly 7 in 10 voters in the state support the reform—including a majority of Republicans. And 63 percent want to see the legislature enact the reform this year, rather than delaying it.

While Gov. Josh Shapiro (D) once again included a proposal to enact cannabis legalization in his latest budget request, there’s been mixed feedback from legislators—some of whom want to see the governor more proactively come to the table to discuss possible pathways for reform and others skeptical about the possibility of advancing the issue this session.

Senate Appropriations Committee Chair Scott Martin (R), for example, said this week that he doesn’t “see any path whatsoever” to enacting legalization in line with the governor’s plan.

At the same time, the state secretary for the Department of Revenue has predicted that Shapiro’s proposal could be passed during the current budget cycle, indicating that he feels reform could start to be implemented within months.

House Majority Leader Matt Bradford (D), meanwhile, said following the governor’s budget speech that “there is real diversity of opinions among our members,” likely referencing split perspectives on regulatory models, with some lawmakers pushing for a state-run cannabis program.

Keep reading

Medical Marijuana Helps Mothers Be ‘More Present Parents’ And Develop ‘Positive Relationships With Their Children,’ Study Finds

New government-funded research out of New Zealand finds that mothers who were able to access medical marijuana reported that cannabis improved their quality of parenting by allowing them to more effectively manage health conditions and tolerate the stress of caring for children.

At the same time, study participants reported persistent obstacles, such as the high cost of legal products and ongoing stigma and legal risks.

The new report, published this week in the journal Drug and Alcohol Review, drew from interviews with 15 mothers who used medical cannabis (MC) obtained either through prescriptions, the illicit market or both during the past year. They were asked about use in general, their conversations with children, societal stigma and risks.

“Mothers reported MC as an important facilitator of their ability to positively parent their children,” the study found, “enabling them to manage their own health needs (i.e., anxiety, endometriosis and arthritis).”

Mothers also reported feeling that “managing their health with MC allowed them to be more present parents and better tolerate the stressors of motherhood,” wrote authors at Massey University in Auckland.

The mothers were recruited for the survey from a larger group of 38 participants who were part of a larger project around women’s relationship with medical marijuana. They were interviewed one-on-one either in person or via an online video call.

“Participants felt that being able to manage their physical pain and mental distress with [medical cannabis] meant they were in a better mood and more present.”

Nearly half the mothers who participated (46.6 percent) said they primarily smoked marijuana, while smaller proportions reported using edibles (40 percent), oils (26.6 percent), vaporization (20 percent), tea (6.7 percent) and topicals (6.7 percent).

Most obtained marijuana through the unregulated, illegal market (53.3 percent), while a third of participants (33.3 percent) reported accessing both prescription and illicit products. Only two mothers (13.3 percent) said they used exclusively prescription products.

Keep reading

CBD Could Effectively Treat Common Vaginal Infections, Study Concludes

Newly published research on cannabidiol (CBD) suggests that the popular marijuana component could be a promising treatment for a common type of vaginal infection.

The report focuses on the bacterium Gardnerella vaginalis, which is found naturally in the vagina but can also cause vaginosis when out of balance with other microbes. In laboratory tests, CBD demonstrated antibacterial and antioxidant effects that weakened G. vaginalis and eliminated communities of the bacteria known as biofilms.

“Our study shows that CBD exhibits antibacterial and antibiofilm activities against G. vaginalis clinical isolates,” the new paper says, “and is thus a potential drug for the treatment of vaginosis caused by this bacterium.”

The article was published this month in a special issue of the journal Antibiotics dedicated to “Antimicrobial and Antibiofilm Activity by Natural Compounds.” It was authored by a four-person team from The Hebrew University of Jerusalem and Hadassah-Hebrew University Medical Center, also in Jerusalem, Israel.

Keep reading

Idaho Lawmakers Send Bill Creating A Mandatory Minimum Fine For Marijuana Possession To Governor’s Desk

The Idaho Senate voted 27-8 on Tuesday to pass a bill creating a mandatory minimum fine of $300 for simple marijuana possession.

Passing the Senate was the final legislative hurdle for the bill. The Idaho House of Representatives already voted 54-14 to pass the bill January 21.

House Bill 7 next heads to Gov. Brad Little’s (R) desk for final consideration. Once it reaches his desk, Little will have three options. He can sign it into law, he can allow it to become law without his signature or he can veto it.

If the bill becomes law it would take effect July 1.

House Bill 7 was co-sponsored by Sen. Brandon Shippy, R-New Plymouth. If passed into law, it would create a mandatory minimum fine of $300 for anybody 18 and over convicted of possessing less than 3 ounces of marijuana—in addition to any other penalties allowed by law.

Supporters of the bill said it is a way to be tough on marijuana and differentiate Idaho from its neighboring states.

Most of Idaho’s neighboring states allow for the recreational or medical use of cannabis. Oregon, Washington, Nevada and Montana allow the recreational sale and possession of cannabis, while Utah offers medical cannabis.

“Not long ago, marijuana was illegal in all 50 states,” Shippy said. “In not one state where marijuana is legalized has that state become a better, safer or more wealthy place to live and raise a family.”

Some opponents of the bill argued against creating a mandatory minimum fine, saying it removes discretion that judges and prosecutors exercise on a case-by-case basis.

The bill is similar to a failed bill from last year, House Bill 606, which would have created a mandatory minimum fine of $420 for marijuana possession.

Keep reading

The origins of cannabis smoking: Chemical residue evidence from the first millennium BCE in the Pamirs

Mind-altering plants can produce various altered states of consciousness and have thus played important roles in ritual and/or religious activities in various areas of the world (14). In prehistoric and early historic Central Eurasia, many plants were used for their secondary compounds, and several are still in prominent use today, notably the opium poppy (Papaver somniferum), ephedra (Ephedra spp.), and cannabis (Cannabis sativa). Plants in the Cannabis genus represent a hybrid complex, with ongoing controversy relating to taxonomy; the lack of taxonomic clarity combined with continual gene flow between wild and domesticated populations has hampered attempts to study the origins and dispersal of this plant (56). Wild cannabis grows across many of the cooler mountain foothills from the Caucasus to western China, especially in the well-watered habitats of Central Asia. However, cannabinol (CBN) levels in most wild cannabis plant populations are low, and it remains a largely unanswered question as to when, where, and how the plant was first cultivated for higher psychoactive tetrahydrocannabinol (THC) production (6). Little is known about the prehistoric use of cannabis outside eastern China, where it was domesticated as an oil-seed crop (78). While recent well-reported and photographed cannabis macroremains have been recovered from burials in the Turpan Basin (ca. 800 to 400 BCE) in northwest China, suggesting shamanic or medicinal uses (910), these discoveries do not adequately reveal how the cannabis plant was used.

Historically, cannabis plants used for ritual and medicinal purposes involved oral ingestion or inhaling the smoke or vapors produced by burning the dried plant. Smoking is defined as the act of inhaling and exhaling the fumes of burning plant material (11) and is today often associated with cigarettes, cigars, and pipes. However, smoking pipes were likely introduced to Eurasia from the New World (12), and no clear evidence exists for them in Central Asia before the modern era. The practice of smoking or inhaling cannabis fumes in ritual and recreational activities was documented in Herodotus’ fifth-century BCE The Histories (13) and was supported by the discovery of carbonized hemp seeds in burials from a handful of sites in Eurasia (11415). However, most of the archaeological reports of ancient drug remains were published several decades ago, and re-examination of some of these reports has led to the claims being refuted (discussed below). Modern scientific studies are thus needed to corroborate the remaining reports. Here, we investigated residues from archaeological artifacts recovered in the Pamir Mountains (Fig. 1Opens in image viewer), a region that served as an important culture communication channel through Eurasia, linking ancient populations in the modern regions of China, Tajikistan, and Afghanistan. The chemical analysis reveals ancient cannabis burning and suggests high levels of psychoactive chemicals, indicating that people may have been cultivating cannabis and possibly actively selecting for stronger specimens or choosing plant populations with naturally high terpenophenolic secondary metabolites (6). Alternatively, a process of domestication through hybridization between wild and cultivated subspecies may have inadvertently led to stronger chemical-producing plants through human dispersal and subsequent selection (7).

Keep reading

GOP Congressman Wants To Talk With RFK Jr. About How ‘Marijuana Is Harmful’ As Trump’s Cabinet Pick Heads To Confirmation Vote

A GOP congressman says it’s “definitely” time to have a talk with President Donald Trump’s pick for head of the U.S. Department of Health and Human Services (HHS) to convince him that “marijuana is harmful” and that the way to make Americans healthy is by “limiting” its use.

After Robert F. Kennedy Jr. was cleared in an initial confirmation vote in the Senate Finance Committee, Rep. Andy Harris (R-MD) told Marijuana Moment that he wanted to have a chat with the potential HHS secretary, who has previously voiced support for cannabis legalization prior to being selected for the top federal health role by Trump.

“Marijuana is harmful,” Harris said in an interview at the Capitol on Wednesday. “We should definitely have a talk with RFK Jr. I mean, the bottom line is: We should keep Americans healthy by limiting the use of marijuana.”

But Harris—a staunchly anti-cannabis lawmaker who has championed legislation to block adult-use marijuana sales in Washington, D.C.—expressed a softer tone when asked about the therapeutic potential of psychedelics, which is another issue that Kennedy has pushed.

The congressman said it “might be possible” that psychedelics could be used in the treatment of conditions such as post-traumatic stress disorder (PTSD).

“We may want to do some more research, but we don’t want to do what D.C. did, which is just make them widely available,” he said, referencing a voter-approved initiative to decriminalize certain psychedelics—which would not inherently increase availability given the lack of any regulated sales component of the reform.

Meanwhile, despite Harris’s apparent concerns about Kennedy’s history of advocating for cannabis legalization, the nominee said last week that he will defer to the Drug Enforcement Administration (DEA) on marijuana rescheduling if confirmed.

That could complicate rescheduling given the fact that the current acting administrator of DEA, Derek Maltz, has made multiple comments expressing hostility to cannabis reform.

Relatedly, prior to Kennedy’s written responses to the Finance Committee, Sen. Elizabeth Warren (D-MA) recently pressed Kennedy to reiterate his position on marijuana legalization amid the ongoing effort to federally reschedule cannabis.

Keep reading